Cart 0

Home ALKtALK Shop

Join

Research Grants ALK Research Library Cutting Edge Trials Clinical Trials ALK Life Study

Get Support What is ALK Treatment & Resources 2nd Opinion Program ALK Summit 2024

About Us Finances Alliances Contact Press

Blog Newsletters Prospectus Annual Report

Donate Ways to Give Fundraise with ALK+

Cart 0

Home Research Research Grants ALK Research Library Cutting Edge Trials Clinical Trials ALK Life Study Patients Get Support What is ALK Treatment & Resources 2nd Opinion Program ALK Summit 2024 About About Us Finances Alliances Contact Press ALKtALK Media Blog Newsletters Prospectus Annual Report Shop

Donate Donate Ways to Give Fundraise with ALK+ Join

Kirk SmithDecember 26, 2021Comment

Facebook0 Twitter LinkedIn0 0 Likes

Case Study, group1Kirk SmithDecember 28, 2021alectinib, osimertinib, brain metastasis, ALK, lung, EGFR, DCTN1-ALK

Clinical Trials, group1Kirk SmithDecember 24, 2021Non-Hodgkin Lymphoma (NHL), Hodgkin Lymphoma (HL), CD30.CAR-T cells, Anaplastic Large Cell Lymphoma (ALCL)

Donate

Join Support Group

info@alkpositive.org

ALK Positive, Inc. 6595 Roswell Road;

Suite G2310 Atlanta, GA 30328

Please send checks to:

ALK LOCKBOX, P.O. Box 24960 New York, New York 10087-4960

Subscribe

Sign up with your email address to receive news and updates.

Email Address

We respect your privacy.

Thank you!

info@alkpositive.org

Hours

Mon Open

Tue Open

Wed Open

Thu Open

Fri Open

Sat Open

Sun Open

Log In Press Home Links Contact Us Blog Privacy Policy

The content on the ALK Positive website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. © ALK Positive, Inc. All Rights Reserved